XML 18 R7.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Cash flows from operating activities:    
Net income (loss) $ (35,156) $ 30,050
Adjustments to reconcile net income (loss) to net cash provided by / (used in) operating activities:    
Depreciation and amortization 6,480 4,283
Amortization of Debt Issue Costs 587 0
Amortization of debt discount 3,366 3,081
Tax benefits from share based payment arrangements (744) 3,694
Share-based compensation 13,036 10,870
Deferred tax benefit (13,982) 2,651
Deferred rent obligations (402) (1,453)
Net loss on disposal of fixed assets 0 31
Contingent liability adjustment 2,135 0
Purchases of securities owned, at fair value (2,085,486) (2,614,177)
Proceeds from sales of securities owned, at fair value 2,219,623 2,634,224
Proceeds from sales of securities sold, not yet purchased, at fair value 1,856,801 1,106,836
Payments to cover securities sold, not yet purchased, at fair value (1,841,743) (1,152,202)
Net (gains) losses on securities, derivatives and other investments 7,731 (54,401)
Consolidated Funds    
Purchases of securities owned, at fair value (22,056) 0
Proceeds from sales of securities owned, at fair value 1,517 0
Proceeds From Securities Sold Not Yet Purchased At Fair Value 2,226 0
Payments to Cover Securities Sold Not Yet Purchased at Fair Value 947 0
Purchases of other investments (221,506) (76,201)
Proceeds from sales of other investments 12,431 5,111
Net realized and unrealized (gains) losses on investments and other transactions 19,100 (6,975)
(Increase) decrease in operating assets:    
Cash collateral pledged (3,687) (944)
Securities owned, at fair value, held at broker dealer 870 (1,357)
Receivable on derivative contracts, at fair value 14,647 (30,224)
Securities borrowed 0 676,100
Receivable from brokers 851 14,313
Fees receivable, net of allowance (10,939) (24,089)
Due from related parties 4,134 (1,406)
Other assets (22,173) (2,324)
Consolidated Funds    
Cash and cash equivalents 5,992 (477)
Receivable on derivative contracts (60) 0
Other assets (584) 985
Increase (decrease) in operating liabilities:    
Securities sold, not yet purchased, at fair value, held at broker dealer (2,029) (1,648)
Payable for derivative contracts, at fair value (6,327) 25,766
Securities loaned 0 (682,493)
Payable to brokers (122,493) 33,835
Compensation payable (145,817) (56,577)
Fees payable (3,114) 382
Due to related parties (65) (115)
Accounts payable, accrued expenses and other liabilities 8,831 (5,458)
Consolidated Funds    
Contributions received in advance (850) 0
Payable to brokers 731 0
Due to related parties 264 0
Accounts payable, accrued expenses and other liabilities 198 122
Net cash provided by / (used in) operating activities (358,609) (160,187)
Cash flows from investing activities:    
Purchases of other investments (24,956) (8,560)
Payments to Acquire Businesses, Net of Cash Acquired 6,258 0
Proceeds from sales of other investments 22,680 36,106
Proceeds from loans held for investments 40,400 0
Purchase of fixed assets (14,694) (1,426)
Net cash provided by / (used in) investing activities 17,172 26,120
Cash flows from financing activities:    
Proceeds from Issuance of Preferred Stock, net of issuance costs 0 117,310
Capped call option transaction 0 15,879
Borrowings on notes and other debt 30,709 2,140
Repayments on notes and other debt (1,901) (1,836)
Income tax effect from share-based payment arrangements (744) 3,694
Proceeds from Stock Options Exercised 0 395
Purchase of treasury stock (6,014) (22,569)
Cash paid to acquire net assets (contingent liability payable) (3,493) (1,725)
Capital contributions by redeemable non-controlling interests in operating entities 0 5,644
Capital withdrawals to redeemable non-controlling interests in operating entities (5,144) (5,723)
Consolidated Funds    
Capital contributions by redeemable non-controlling interests in Consolidated Funds 231,871 71,202
Capital withdrawals to redeemable non-controlling interests in Consolidated Funds (4,549) (2,388)
Net cash provided by / (used in) financing activities 240,735 150,265
Change in cash and cash equivalents (100,702) 16,198
Cash and cash equivalents at beginning of period 158,485 129,509
Cash and cash equivalents at end of period 57,783 145,707
Supplemental information    
Purchase of treasury stock, at cost, through net settlement 8,562 8,520
Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed) 7,164 0
Preferred stock dividends declared 3,396 755
Net Assets of Deconsolidated Entity $ 73,042 $ 0